DOLOMITE - Safety and effectiveness of DTG use in pregnancy

 

A multi-site observational study to define the safety and effectiveness of Dolutegravir use in HIV positive pregnant women

 

Indication:  HIV positive women receiving DTG (at least 200 starting or on DTG in the first trimester)

 

Phase: IV

 

Countries:  UK, spain, Portugal, France, Italy, Belgium, Poland & Ukraine

​

Sites: 21 & Counting

 

Status: Actively recruiting